The Gateway is a single portal to manage licenses, permits, and registrations with the North Carolina Board of Pharmacy. Access printable documents, update information, submit applications, and more.
Click HereBoard members and staff thank Andy Bowman for eight years of superlative service to the Board and the citizens of North Carolina. Dr. Bowman has accepted an exciting personal and professional opportunity with the Appalachian College of Pharmacy (read more below)
Read MoreWith Dr. Bowman’s departure, the Board is required to select a pharmacist to fulfill the remainder of his term of service. The pharmacist members of the Board solicited nominations from qualified pharmacists (read more below)
Read More
NCBOP Office, 6015 Farrington Road, Suite 201
Chapel Hill, NC 27517. The meeting will begin at 9:30AM with a hearing to consider proposed rule changes.
You already follow us on Twitter/X. Now the Board is happy to introduce our new Instagram page. Follow us for news updates, information, photos, live streaming and more!
Details about these new plans may be found here. Questions about these new plans should be directed to North Carolina Medicaid.
The NCBOP and NCPHP established the L. Stanley Haywood Recovery Fund in 2018. It provides financial support to qualifying pharmacy personnel in need of substance use assessment, treatment, and monitoring services. Learn more about donating or applying for assistance.
Read MoreProhibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act.
Read MoreA public hearing will be held at 9:30AM on Tuesday, July 9, 2024 at the Board’s office to consider these changes.
Read MoreOptometrists who dispense certain prescription drugs may now register with the Board of Pharmacy. The initial registration fee is $75 and requires an annual renewal.
Read More
Board meetings are live-streamed and past meetings are archived here.
july 5, 2024
Board members and staff thank Andy Bowman for eight years of superlative service to the Board and the citizens of North Carolina. The state’s pharmacists elected Dr. Bowman in 2016, and he became the first graduate of the Campbell University College of Pharmacy and Health Sciences to serve on the Board. The state’s pharmacists returned Dr. Bowman to a second term on the Board in 2021. He twice served as the Board’s president.
Dr. Bowman has accepted an exciting personal and professional opportunity with the Appalachian College of Pharmacy where he will serve as assistant dean for strategic partnerships and engagement. This new opportunity will require Dr. Bowman’s relocation to Virginia.
Dr. Bowman’s impact on the practice of pharmacy in North Carolina has been profound. In addition to serving on the Board, he taught generations of students at the Campbell University College of Pharmacy and Health Sciences. He served in leadership positions at the North Carolina Association of Pharmacists, the North Carolina Pharmacist Recovery Network (and its successor, the North Carolina Professionals Health Program), the American Society for Pharmacy Law, and the Harnett County Pharmaceutical Association.
North Carolina pharmacy is better because of Dr. Bowman’s long and broad service. He will be missed. Board members and staff wish him and his wife, Sarah, every success in this new phase.
july 5, 2024
With Dr. Bowman’s departure, the Board is required to select a pharmacist to fulfill the remainder of his term of service. The pharmacist members of the Board solicited nominations from qualified pharmacists. After reviewing these pharmacists’ submissions, as well as holding a public interview and discussion session for all candidates at the May 21, 2024 business meeting, pharmacist members elected Robert J. “Joey” McLaughlin, Jr, to fulfill the unexpired term, which runs through April 30, 2026.
Mr. McLaughlin is from New Bern, NC, and is the president and chief executive officer of Realo Drugs, which operates several community retail pharmacies and a device and medical equipment facility. Mr. McLaughlin’s practice background is broad, and he is a well-liked and well-respected member of the North Carolina pharmacy community. Mr. McLaughlin previously served on the Board from 2006-2016, and his service was exemplary.
Board members and staff also thank Jennifer Buxton, Jason Foil, Karen Harrell-Tosto, Wes Hickman, Amanda Lingerfelt, Brian Moore, and Jack Pate for their candidacies.
JUNE 18, 2024
Details about these new plans may be found here. Questions about these new plans should be directed to North Carolina Medicaid.
june 7, 2024
NCBOP members and staff are pleased to share our updated website! The URL – www.ncbop.org – remains the same, but you will see improvements to the site including a cleaner, more user-friendly interface; reorganized and more easily searchable frequently asked questions (FAQs) sections; and modules for each type of license, permit, and registration that the Board issues. Please contact us if you have questions or trouble finding information.
JUNE 29, 2023
On June 27, 2023 the federal Food and Drug Administration (“FDA”) issued a draft guidance document titled “Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act.” Section 503B states that an outsourcing facility is not eligible for the statutory exemptions for its compounded product if the product is sold or transferred by an “entity other than the outsourcing facility that compounded such drug.” Board staff have received calls from time to time inquiring whether this provision prohibits pharmacies from purchasing a compounded prescription product from a 503B outsourcing facility and then dispensing it to a patient pursuant to an individual patient prescription. FDA’s draft guidance states, among other things, that the following situations would not be subject to Section 503B’s wholesaling prohibition:
* An outsourcing facility distributes a drug it compounded (without obtaining a patient-specific prescription) to a health care professional who administers it in a health care setting (e.g., in a hospital or the physician’s office)
* An outsourcing facility distributes a drug it compounded (without obtaining a patient-specific prescription) to a hospital or health system, health clinic, or physician’s office, and it is administered within that hospital or health system, health clinic, or physician’s office.
* An outsourcing facility distributes a drug it compounded (without obtaining a patient-specific prescription) to a hospital or health system, health clinic, or physician’s office where it is used as office stock to dispense to patients pursuant to prescriptions.
* An outsourcing facility distributes a drug it compounded to a state-licensed pharmacy, federal facility, or licensing physician, which subsequently dispenses the drug pursuant to a prescription.
The draft guidance is found here: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/prohibition-wholesaling-under-section-503b-federal-food-drug-and-cosmetic-act. The title page of the draft guidance contains instructions to submit comments and suggestions within 60 days.
FEBRUARY 27, 2024
Optometrists may now register with the NC Board of Pharmacy to dispense certain prescription drugs. G.S. § 90-127.4. Dispensing optometrists may dispense prescription drugs to their own patients only for the diagnosis and treatment of abnormal conditions of the eye and its adnexa. G.S. § 90-127.4(a) & (c). Dispensing optometrists may not compound medications, nor may they dispense controlled substances. G.S. § 90-127.4(a).
Dispensing optometrists must register with the Board of Pharmacy prior to beginning dispensing activities and must renew that registration annually. G.S. § 90-85.26B. The initial registration fee is $75, as is the annual renewal fee. G.S. § 90-85.24(a)(20).
A dispensing optometrist must comply in all respects with relevant laws and regulations that apply to pharmacists governing the distribution of drugs, including packaging, labeling, and record keeping. G.S. § 90-85.26B. The Board of Pharmacy may discipline a dispensing optometrist’s registration for violation of these laws and regulations. The Board of Optometry may discipline an optometrist’s license to practice optometry. G.S. § 90-85.25B.
Step-by-step instructions for completing a dispensing optometrist registration are found here.
MARCH 11, 2024
Today (March 11, 2024), NC DHHS issued an updated COVID-19 treatment provider memo. Included in this memo is a reminder that EUA-labeled Paxlovid is no longer authorized for use, information about PAXCESS – a program that can help patients with financial barriers obtain Paxlovid, an update on clinical data on the efficacy of antiviral treatments, and a note on the large portion of the North Carolina population considered high risk based on age or health conditions. The memo is found here.